"Passionate about improving cattle health & welfare through innovation, excellence & valued & trusted customer support."

Belgian and Spanish Stakeholders Join EPRUMA

EPRUMA is happy to welcome AMCRA and VETRESPONSABLE, the Belgian and Spanish stakeholder platforms for the Responsible Use of veterinary medicines, as associate members. Having AMCRA and VETRESPONSABLE on board means a strengthened representation for EPRUMA.

Promoting coordination and exchange of information with national Responsible Use initiatives is an important EPRUMA objective. EPRUMA partners work together to promote the Responsible Use of veterinary medicines in the EU by looking into best practices at national level.

EPRUMA's chairman, Gwyn Jones, said "I am honoured to welcome AMCRA and VETRESPONSABLE to our European platform and look forward to working with all our partners and stakeholders to promote the Responsible Use of veterinary medicines in Europe for the health and welfare of animals, as well as food safety and public health". Read More

For further information of the European Platform for the Responsible Use of Medicines in Animals visit: www.epruma.eu

An educational service from Boehringer Ingelheim Limited, Vetmedica Division, the makers of Metacam®, Bovikalc®, Ubrolexin®, Ubro Yellow®, Ubro Red® and Mamyzin®.

Advice on the use of Metacam, Bovikalc or other therapies should be sought from your veterinary surgeon. Metacam contains meloxicam, UK: POM-V IE: POM. Bovikalc contains calcium chloride and calcium sulphate and is not a veterinary medicine which is subject to authorisation by the Irish Medicines Board. Further information available from Boehringer Ingelheim Limited, Vetmedica Division, Bracknell, Berkshire, RG12 8YS, UK. Email: vetmedica.uk@boehringer-ingelheim.com | Web: www.boehringer-ingelheim.co.uk

See our Terms of Use

Date of preparation: Jul 2013. AHD 7729. Use Medicines Responsibly (www.noah.co.uk/responsible)